anti-CD3/anti-ROR1 bispecific T-cell engager DART (MacroGenics)

N/A

Report date: 2026/03/19 16:58:20

Base Information

Drug Nameanti-CD3/anti-ROR1 bispecific T-cell engager DART (MacroGenics)
Drug Alias NameROR1xCD3 DART antibodies (MacroGenics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionT cell surface glycoprotein CD3 modulatorsInactive tyrosine-protein kinase transmembrane receptor ROR1 modulators
TargetsT cell surface glycoprotein CD3Inactive tyrosine-protein kinase transmembrane receptor ROR1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMacrogenics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMacrogenics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A